FGF23 y enfermedades óseas
Barra lateral del artículo
Contenido principal del artículo
Detalles del artículo
Derechos de autor: Actualizaciones en Osteología es la revista oficial de la Asociación Argentina de Osteología y Metabolismo Mineral (AAOMM) que posee los derechos de autor de todo el material publicado en dicha revista.
Citas
Martínez-Heredia L, Canelo-Moreno JM, García-Fontana B, Muñoz-Torres M. Non-Classical Effects of FGF23: Molecular and Clinical Features. Int J Mol Sci 2024;25:4875. doi: 10.3390/ijms25094875.
Aono Y, Yamazaki,Y, Yasutake J, et al. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia. J Bone Miner Res 2009; 24:1879-88. doi: 10.1359/jbmr.090509.
Quarles LD. Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions. Curr Opin Nephrol Hypertens 2019; 28:16-25. doi:10.1097/MNH.0000000000000467.
Rivoira MA, Peralta López ME, Areco V, Díaz de Barboza G, Dionisi MP, Tolosa de Talamoni N. Emerging concepts on the FGF23 regulation and activity. Mol Cell Biochem 2024 Apr 6. doi: 10.1007/s11010-024-04982-6.
Minisola S, Fukumoto S Xia W, et al. Tumor-induced osteomalacia: a comprehensive review. Endocr Rev 2023;44:323-53. doi: 10.1210/endrev/bnac026.
Zhang H, Xiang G, Li J, et al. Promotion effect of FGF23 on osteopenia in congenital scoliosis through FGFr3/TNAP/OPN pathway. Chin Med J (Engl) 2023;136:1468-77. doi: 10.1097/CM9.0000000000002690.
Vogt I, Haffner D, Leifheit-Nestler M. FGF23 and Phosphate-Cardiovascular Toxins in CKD. Toxins (Basel) 2019;11:647. doi: 10.3390/toxins11110647.
Zuo Q, Yang W, Liu B, et al. A novel FGF23 mutation in hyperphosphatemic familial tumoral calcinosis and its deleterious effect on protein O-glycosylation. Front Endocrinol (Lausanne) 2022;13:1008800. doi: 10.3389/fendo.2022.1008800.
Wang K, Zhang R, Chen Z, Bai Y, He Q. Meta-analysis and systematic review: burosumab a s a promising treatment for children with X-linked hypophosphatemia Front Endocrinol (Lausanne) 2024;15:1414509. doi: 10.3389/fendo.2024.1414509.
Álvarez-Rivas N, Lugo-Rodríguez G, Maneiro JR, et al. Tumor-induced osteomalacia: A systematic literature review Bone Rep 2024; 8(21):101772. doi: 10.1016/j.bonr.2024.101772.
Michon-Colin A, Bouderlique E, Prié D , et al. Successful Burosumab Treatment in an Adult Patient with X-Linked Hypophosphatemia and Chronic Kidney Disease Stage 3b. Calcif Tissue Int 2024;114:310-4. doi: 10.1007/s00223-023-01169-x.